Hospital Research on Depression Seeks Study Participants
New Britain [December 29 2005] -
In any given one-year period, 9.5 percent of the population, or about 18.8 million American adults, suffer from a depressive illness, according to estimates by the National Institute of Mental Health.
If you or a family member are living with depression, you may be eligible to participate in one of the clinical research studies being conducted by the behavioral health research department at New Britain General Hospital. The department is actively seeking research participants. Eligibility criteria vary, but generally, participants should be between the ages of 18 and 65, and be in generally good health.
The goal of the clinical research study is to determine the efficacy of a new medication for treatment of depression.
There are many benefits of participating in clinical research. Eligible participants will receive a complete physical and full blood work-up, various therapies and possibly new medications, all at no cost. Participants may be able to try new medications and/or treatments under development before they are made available to the general public. New medications may improve symptoms, possibly with fewer side effects than current treatments.
In addition, through regular meetings, research staff function as an extended support system for participants by listening, educating, and providing resources along the way. Research staff is also available during daytime hours, seven days a week to answer questions and concerns.
After completing the study, research staff continues to support participants by assisting them in obtaining follow-up care.
By providing information to the research staff, study participants have the opportunity to contribute to the development of treatments for their conditions that may help others in the future.
In addition to receiving treatment at no cost, participants are reimbursed for their time, meals, and transportation.
The prinicipal investigator, Mahlon S. Hale, MD, has been conducting clinical trials for more than 10 years with a highly-trained team of professionals.
To learn more about these studies, please call Alison Oville, project manager, in Dr. Mahlon Hale’s office at 860-224-5597.
Contact: Corporate Communications, 860-224-5900 x6507
HCC Corporate Communications
(860) 224-5695 •
Fax (860) 224-5779